Wick Capital Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-541
Closed -$283K 114
2025
Q1
$283K Sell
541
-14
-3% -$7.16K 0.08% 84
2024
Q4
$280K Buy
555
+74
+15% +$42K 0.08% 81
2024
Q3
$281K Hold
481
0.09% 66
2024
Q2
$245K Buy
481
+16
+3% +$7.84K 0.08% 68
2024
Q1
$230K Hold
465
0.22% 41
2023
Q4
$245K Buy
465
+53
+13% +$28.3K 0.1% 60
2023
Q3
$208K Buy
+412
New +$203K 0.12% 62
2023
Q2
Sell
-433
Closed -$204K 65
2023
Q1
$204K Buy
433
+45
+12% +$21.7K 0.12% 64
2022
Q4
$206K Buy
+388
New +$206K 0.12% 55
2022
Q2
Sell
-1,035
Closed -$528K 67
2022
Q1
$528K Sell
1,035
-278
-21% -$134K 0.35% 28
2021
Q4
$659K Buy
+1,313
New +$594K 0.51% 26

Other funds holding UNH

Wick Capital Partners's UNH Position: Q2 2025 in Review

Wick Capital Partners sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 541 shares — an estimated $283K sold.

Wick Capital Partners first reported a position in UNH in Q4 2021 and held it in 11 quarters. The position peaked at $659K in Q4 2021. 3,177 funds tracked by Wall St. Rank hold UNH as of Q2 2025.

  • Wick Capital Partners reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
  • Wick Capital Partners sold 541 UnitedHealth shares in Q2 2025, an estimated $283K.
  • Wick Capital Partners first reported a position in UnitedHealth in Q4 2021 and held it in 11 quarters.
  • Wick Capital Partners's UnitedHealth position peaked at $659K in Q4 2021.
  • 3,177 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.

Based on Wick Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.